Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA
MC Mithoefer, CS Grob, TD Brewerton - The Lancet Psychiatry, 2016 - Elsevier
Abstract
phosphorloxy-N, N-dimethyltryptamine (psilocybin) and methylenedioxymethamfetamine (MDMA), best known for their illegal use as psychedelic drugs, are showing promise as therapeutics in a resurgence of clinical research during the past 10 years. Psilocybin is …
Author
Last updated: Jul 27, 2020